- Home
- ICAD vs VOR Comparison
ICAD vs VOR Comparison
Compare ICAD & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICAD
- VOR
- Stock Information
- Founded
- ICAD 1984
- VOR 2015
- Country
- ICAD United States
- VOR United States
- Employees
- ICAD N/A
- VOR N/A
- Industry
- ICAD Medical/Dental Instruments
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- ICAD Health Care
- VOR Health Care
- Exchange
- ICAD Nasdaq
- VOR Nasdaq
- Market Cap
- ICAD 93.9M
- VOR 85.7M
- IPO Year
- ICAD 1986
- VOR 2021
- Fundamental
- Price
- ICAD $3.60
- VOR $0.15
- Analyst Decision
- ICAD Hold
- VOR Buy
- Analyst Count
- ICAD 1
- VOR 7
- Target Price
- ICAD N/A
- VOR $7.83
- AVG Volume (30 Days)
- ICAD 1.8M
- VOR 1.2M
- Earning Date
- ICAD 05-19-2025
- VOR 05-20-2025
- Dividend Yield
- ICAD N/A
- VOR N/A
- EPS Growth
- ICAD N/A
- VOR N/A
- EPS
- ICAD N/A
- VOR N/A
- Revenue
- ICAD $19,608,000.00
- VOR N/A
- Revenue This Year
- ICAD $2.58
- VOR N/A
- Revenue Next Year
- ICAD $14.78
- VOR N/A
- P/E Ratio
- ICAD N/A
- VOR N/A
- Revenue Growth
- ICAD 13.22
- VOR N/A
- 52 Week Low
- ICAD $1.18
- VOR $0.15
- 52 Week High
- ICAD $3.78
- VOR $1.87
- Technical
- Relative Strength Index (RSI)
- ICAD 72.92
- VOR 14.55
- Support Level
- ICAD $3.42
- VOR $0.65
- Resistance Level
- ICAD $3.58
- VOR $0.85
- Average True Range (ATR)
- ICAD 0.13
- VOR 0.07
- MACD
- ICAD 0.03
- VOR -0.05
- Stochastic Oscillator
- ICAD 78.08
- VOR 2.67
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.